BLT 0.00% 2.6¢ benitec biopharma limited

Trial time table, page-6

  1. 2,129 Posts.
    lightbulb Created with Sketch. 3
    BLT future gets bleaker and bleaker - may explain recent selling

    http://www.fiercepharma.com/story/m...ombo-it-preps-battle-gilead-abbvie/2016-01-29

    Merck sets $54K list price for hep C combo as it preps for battle with Gilead, AbbVie

    January 29, 2016 | By Carly Helfand

    Industry watchers have long been speculating on how Merck would take on heavyweights Gilead ($GILD) and AbbVie ($ABBV) when it priced its new hep C regimen. And now, they have their answer: Undercut them. Big-time.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.